NCT01475097 Clinical Trial Information | SourceSolution's Biotech, Pharma, CMO, CRO Directory

Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography


Sponsors: GE Healthcare i3 Statprobe	Phases: Phase IV
Indications	Acronym:
Drug Safety
Age Groups: Adult Senior	Gender: Both
Names: Drug: Iodixanol Drug: Iopamidol	Enrollment: 250

Additional information about NCT01475097.